Yaz, Yasmin, and Gardasil Warning labels

mhoMedicationLeave a Comment

This article is devoted to young women.  It has been my concern for several years the many adverse effects of the medications sold to women can cause permanent harm.  I hope this is helpful in protecting our beautiful young ladies who need all the help they can get in navigating this crazy world. 

Gardasil is one of the most high profile vaccinations.  It was originally developed to prevent cervical cancer caused by the virus called HPV, human papillomavirus.  The vaccine covers 4 strains of the myriad of variations of the virus.  Two of the variations of the virus that are covered by Gardasil cause cervical cancer in 3.2% of the cases.

The vaccine adverse event reporting system has over 21,000 reports of adverse event related to this vaccine, including over 90 deaths.  Some of the adverse reactions to this vaccine include multiple sclerosis, Guillain-Barre Syndrome, blindness, lupus, rheumatoid arthritis, paralysis, blood clots and death.

What’s more is this vaccine’s protection window lasts 4 – 6 years.  Girls are often advised to receive the vaccine at the age of 12.  This means that by the time the girl turns 19 years old, the protection has diminished.

Yaz and Yasmin may cost Bayer $1.2 billion in personal injury lawsuits.  Bayer is currently facing 12,325 Yaz and Yasmin lawsuits.  This oral contraceptive contains drospirenone, a synthetic progestin.  This medication increases the risk of clot more than other types of oral birth control.  The clot injuries include deep vein thrombosis and pulmonary embolism among other clot locations.

In April, the Food and Drug Administration release a safety announcement that drospirenone-containing oral contraceptives may be associated with higher risk of -blood clots than progestin-containing pills.

Please contact Roger Smith, a lawyer for Beasley Allen, at 800-898-2034 or email Roger.Smith@beasleyallen.com.


mhoYaz, Yasmin, and Gardasil Warning labels

Leave a Reply

Your email address will not be published. Required fields are marked *